ArticlemSphere2020
Origin of OXA-23 Variant OXA-239 from a Recently Emerged Lineage of Acinetobacter baumannii International Clone V.
Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Genomic signatures of dominant clones and evolutionary divergence ofMicrobial genomics · 2026Article
- Global multi-host genomic epidemiology of Acinetobacter baumannii reveals transmission at one health interfaces.Nature communications · 2026Article
- Comparative genomics of carbapenem-resistantMicrobiology spectrum · 2025Article
- Global emergence ofMicrobial genomics · 2025Article
- Review
- Genomic epidemiology reveals antibiotic resistance transfer and polyclonal dissemination ofAntimicrobial agents and chemotherapy · 2025Article
- Emergence and global spread of a dominant multidrug-resistant clade within Acinetobacter baumannii.Nature communications · 2025Article
- Article
- Article
- Article
- Article
- Pandrug-resistantFrontiers in cellular and infection microbiology · 2023Article
- Phylogenomics ofFrontiers in microbiology · 2023Article
- Acinetobacter baumannii Sampled from Cattle and Pigs Represent Novel Clones.Microbiology spectrum · 2022Article
- Diversity of carbapenem-resistantMicrobial genomics · 2022Article
- Genomic Characterization of Mobile Genetic Elements Associated With Carbapenem Resistance ofFrontiers in microbiology · 2022Article
- The promiscuous and highly mobile resistome ofMicrobial genomics · 2022Article
- Article
- The Population Structure ofMicroorganisms · 2021Article
- Mechanisms ProtectingInternational journal of molecular sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last few decades, carbapenemase-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.